Zinplava
Payments companies reported to CMS as associated with Zinplava. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zinplava, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zinplava
These are the largest totals companies reported as associated with Zinplava. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Erik Dubberke | Saint Louis, MO | Infectious Disease | $7,323.75 |
| Meghan Harris | Tampa, FL | Infectious Disease | $174.81 |
| Timothy Ramos | Brandon, FL | Nurse Practitioner | $163.57 |
| Lisa Kriney | Doylestown, PA | Adult Health (Nurse Practitioner) | $161.33 |
| Kimberly Williams Bidwell | Pennington, NJ | Family | $142.77 |
| Varujan Keledjian | Walnut Creek, CA | Gastroenterology (Internal Medicine) | $128.93 |
| Amy Brettman | Shawnee, KS | Physician Assistant | $124.40 |
| Jose Vasquez | Brandon, FL | Infectious Disease | $116.89 |
| Shana Arnhold | Shawnee, KS | Medical | $108.72 |
| Yagneshvari Patel | Tampa, FL | Infectious Disease | $102.71 |
Prescribed Zinplava?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.